Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2018
DOI: 10.1089/jmf.2017.0138
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory Diseases of the Gut

Abstract: Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract whose prevalence has been dramatically increasing over the past decade. New studies have shown that IBD is the second most common chronic inflammatory disease worldwide after rheumatoid arthritis, affecting millions of people mainly in industrialized countries. Symptoms of IBD include frequent bloody diarrhea, abdominal cramping, anorexia, abdominal distension, a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
20
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 26 publications
(20 citation statements)
references
References 161 publications
0
20
0
Order By: Relevance
“…IBD is a multifactorial immune disorder characterized by chronic inflammation and apoptosis of intestinal cells, which lead to intestinal mucosa damage, oxidative stress, and activation of immune cells with multiple inflammatory mediators ( 48 51 ). The soluble factors produced by probiotics, for which the term of “postbiotic” was recently coined, have been reported to alleviate the IBDs ( 22 , 25 , 52 ).…”
Section: Discussionmentioning
confidence: 99%
“…IBD is a multifactorial immune disorder characterized by chronic inflammation and apoptosis of intestinal cells, which lead to intestinal mucosa damage, oxidative stress, and activation of immune cells with multiple inflammatory mediators ( 48 51 ). The soluble factors produced by probiotics, for which the term of “postbiotic” was recently coined, have been reported to alleviate the IBDs ( 22 , 25 , 52 ).…”
Section: Discussionmentioning
confidence: 99%
“…Inflammatory bowel disease (IBD) . IBD, including ulcerative colitis (UC) and Crohn’s disease (CD), is characterized by chronic inflammation in the gastrointestinal tract influenced by several factors, including genetics, epigenetics, gut microbiota, and the host immune system [ 55 ]. There have been many RCTs evaluating the effects of probiotics in IBD, associated with ample evidence suggesting that altered gut microbiota contribute to the initiation and progression of IBD.…”
Section: Effects Of Probiotics In High-risk Populations With Immunmentioning
confidence: 99%
“…Patients with IBD also suffer from other complications, such as intestinal ulceration, rupture, and strictures, leading to the obstruction of the gastrointestinal tract. Moreover, patients with IBD have an increased risk of colon cancer, in addition to other systemic manifestations, which cumulatively result in serious complications that significantly impacts quality of life [ 3 ].…”
Section: Introductionmentioning
confidence: 99%